Form 4: Genasys CFO Dennis Klahn Awarded Stock Options

Genasys CFO Dennis Klahn was granted options to purchase 90,000 shares of the company's common stock.

Summary

• Genasys Inc. CFO/Secretary Dennis D. Klahn was granted options to purchase 90,000 shares of the company's common stock on December 12, 2024.
• The options have an exercise price of $2.59 per share.
• The options vest in three equal installments: one-third on December 12, 2025, one-third on December 12, 2026, and one-third on December 12, 2027.
• The options expire on December 12, 2031.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.

Positives

• The grant of stock options aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The vesting schedule suggests a long-term incentive plan for the CFO.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard practice for executive compensation across various industries.
• The vesting schedule of one-third annually is a common approach to incentivize long-term performance.
• The exercise price of $2.59 is specific to Genasys and its current stock valuation.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the CFO to improve company performance.
• The grant does not have an immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, executive compensation, insider trading, Genasys, GNSS, Dennis Klahn, CFO